OXA β-lactamases

BA Evans, SGB Amyes - Clinical microbiology reviews, 2014 - Am Soc Microbiol
The OXA β-lactamases were among the earliest β-lactamases detected; however, these
molecular class D β-lactamases were originally relatively rare and always plasmid …

[HTML][HTML] Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace

MS Ramirez, RA Bonomo, ME Tolmasky - Biomolecules, 2020 - mdpi.com
Acinetobacter baumannii is a common cause of serious nosocomial infections. Although
community-acquired infections are observed, the vast majority occur in people with …

[HTML][HTML] Antibiotic adjuvants–A strategy to unlock bacterial resistance to antibiotics

C González-Bello - Bioorganic & medicinal chemistry letters, 2017 - Elsevier
Resistance to available antibiotics in pathogenic bacteria is currently a global challenge
since the number of strains that are resistant to multiple types of antibiotics has increased …

An update on β-lactamase inhibitor discovery and development

JD Docquier, S Mangani - Drug Resistance Updates, 2018 - Elsevier
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …

β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs

C Gonzalez-Bello, D Rodríguez, M Pernas… - Journal of medicinal …, 2019 - ACS Publications
Infections caused by resistant bacteria are nowadays too common, and some pathogens
have even become resistant to multiple types of antibiotics, in which case few or even no …

[HTML][HTML] New carbapenemase inhibitors: clearing the way for the β-lactams

JC Vázquez-Ucha, J Arca-Suárez, G Bou… - International journal of …, 2020 - mdpi.com
Carbapenem resistance is a major global health problem that seriously compromises the
treatment of infections caused by nosocomial pathogens. Resistance to carbapenems …

New β-lactamase inhibitors: a therapeutic renaissance in an MDR world

SM Drawz, KM Papp-Wallace… - Antimicrobial agents and …, 2014 - Am Soc Microbiol
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …

New β-lactamase inhibitors in the clinic

KM Papp-Wallace, RA Bonomo - Infectious Disease Clinics, 2016 - id.theclinics.com
Infect Dis Clin N Am 30 (2016) 441–464 http://dx. doi. org/10.1016/j. idc. 2016.02. 007 id.
theclinics. com 0891-5520/16/$–see front matter© 2016 Elsevier Inc. All rights reserved …

The rise of carbapenem-resistant Acinetobacter baumannii

BA Evans, A Hamouda… - Current pharmaceutical …, 2013 - ingentaconnect.com
Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult
pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to …

Strategic approaches to overcome resistance against Gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel …

KM Papp-Wallace, NQ Nguyen… - Journal of medicinal …, 2018 - ACS Publications
Limited treatment options exist to combat infections caused by multidrug-resistant (MDR)
Gram-negative bacteria possessing broad-spectrum β-lactamases. The design of novel β …